MiT family translocation renal cell carcinoma in an elderly male

Prachi1, Hema Mailini Aiyer1

  • 1Department of Pathology, Dharamshila Narayana Superspeciality Hospital, New Delhi, India.

Insights

Translocation-associated renal cell carcinoma (t-RCC) involves gene rearrangements of TFE3 or TFEB. This report details an unusual case of TFE3-positive Xp11 translocation renal cell carcinoma in a 52-year-old male.

Area of Science:

  • Oncology
  • Genetics
  • Pathology

Background:

  • Translocation-associated renal cell carcinoma (t-RCC) is a rare kidney cancer subtype defined by TFE3/TFEB gene rearrangements.
  • TFE3/TFEB are microphthalmia transcription factors crucial for cell differentiation.
  • t-RCCs, including Xp11 and t(6;11) types, exhibit diverse histology and are more prevalent in pediatric populations.

Observation:

  • The study presents a rare case of TFE3-positive Xp11 translocation renal cell carcinoma.
  • This specific t-RCC occurred in a 52-year-old male, an atypical demographic given the typical age range.

Findings:

  • Histological features of t-RCC include papillary, alveolar, or nested growth patterns with specific cell types and psammoma bodies.
  • Immunohistochemical stains like PAX8, AMACR, and TFE3 are vital for diagnosis.
  • The case highlights the importance of considering t-RCC in adult patients, despite its rarity.

Implications:

  • Accurate diagnosis of t-RCC is critical due to its distinct clinical behavior and treatment considerations.
  • Ancillary testing, including molecular analysis and specific immunohistochemistry, is essential for differentiating t-RCC from mimics.
  • This case underscores the need for vigilance in diagnosing t-RCC across all age groups.